Log In
BCIQ
Print this Print this
 

Factive, gemifloxacin mesylate (ARB-FV0127)

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionBroad spectrum fluoroquinolone antibiotic
Molecular Target DNA gyrase ; Topoisomerase IV
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$1.0M

$5.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today